{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:24:37Z","timestamp":1787761477753,"version":"build-2784847793"},"reference-count":40,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC)","award":["PIFIISC23\/07"],"award-info":[{"award-number":["PIFIISC23\/07"]}]},{"name":"Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC)","award":["RICORS-RD24\/0007\/0031"],"award-info":[{"award-number":["RICORS-RD24\/0007\/0031"]}]},{"name":"Next Generation EU funds","award":["PIFIISC23\/07"],"award-info":[{"award-number":["PIFIISC23\/07"]}]},{"name":"Next Generation EU funds","award":["RICORS-RD24\/0007\/0031"],"award-info":[{"award-number":["RICORS-RD24\/0007\/0031"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Objective: 3-Nitrotyrosine (3-NT) is a byproduct of tyrosine nitration, mediated by reactive nitrogen species such as peroxynitrite and nitrogen dioxide. It serves as a marker of cellular damage, inflammation, and nitric oxide activity. Rheumatoid arthritis (RA) is a complex autoimmune disease characterized by systemic involvement and increased oxidative stress. In RA patients, cardiovascular disease has emerged as the leading cause of mortality. This study aimed to investigate the relationship between serum 3-NT levels and various disease characteristics in RA patients, with a particular focus on cardiovascular comorbidities. Methods: A total of 168 RA patients were recruited. They underwent comprehensive evaluations, including disease-related characteristics and disease activity indices. Furthermore, a comprehensive lipid panel, measures of insulin resistance, metabolic syndrome criteria, and carotid ultrasound to evaluate intima\u2013media thickness and the presence of carotid plaques were conducted. 3-NT serum levels were measured. A multivariable linear regression analysis was performed to examine the associations between the disease characteristics and 3-NT. Results: After multivariable analysis, C-reactive protein was independently associated with higher serum levels of 3-NT. In contrast, disease characteristics and Disease Activity Score 28-joint count (DAS28) calculated using C-reactive protein or erythrocyte sedimentation rate, showed no significant association with 3-NT levels. Likewise, cardiovascular comorbidities, including lipid profiles, insulin resistance indices, metabolic syndrome, and markers of subclinical atherosclerosis did not demonstrate any significant relationship with 3-NT levels. Conclusions: While 3-NT levels are influenced by inflammation, they do not appear to be strongly associated with disease characteristics, cardiovascular risk, or disease-modifying anti-rheumatic drugs in RA patients. This emphasizes the complexity of oxidative stress in RA.<\/jats:p>","DOI":"10.3390\/diagnostics15111325","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:16:22Z","timestamp":1748204182000},"page":"1325","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship of Serum 3-Nitrotyrosine Levels with Inflammation in Patients with Rheumatoid Arthritis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-9072","authenticated-orcid":false,"given":"Juan C.","family":"Quevedo-Abeledo","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Hospital Doctor Negr\u00edn, 35010 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-1943","authenticated-orcid":false,"given":"Fuensanta","family":"G\u00f3mez-Bernal","sequence":"additional","affiliation":[{"name":"Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-5308","authenticated-orcid":false,"given":"Mar\u00eda","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Almeida-Santiago","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Doctor Negr\u00edn, 35010 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Abreu-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Unit of Physiology, Department of Basic Medical Sciences, University of La Laguna, 38200 Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4702-1840","authenticated-orcid":false,"given":"Candelaria","family":"Mart\u00edn-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of La Laguna (ULL), 38200 Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-7406","authenticated-orcid":false,"given":"Miguel \u00c1.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"},{"name":"Department of Medicine and Psychiatry, University of Cantabria, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5267","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain"},{"name":"Department of Internal Medicine, University of La Laguna (ULL), 38200 Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the Joints, the Extra-Articular Manifestations in Rheumatoid Arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/art.23811","article-title":"The Risk of Myocardial Infarction and Pharmacologic and Nonpharmacologic Myocardial Infarction Predictors in Rheumatoid Arthritis: A Cohort and Nested Case-Control Analysis","volume":"58","author":"Wolfe","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of Cardiovascular Mortality in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies","volume":"59","author":"Choi","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3899\/jrheum.200435","article-title":"Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus","volume":"48","author":"Ojeda","year":"2021","journal-title":"J. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3899\/jrheum.180198","article-title":"Relationship between Insulin Sensitivity and \u03b2-Cell Secretion in Nondiabetic Subjects with Rheumatoid Arthritis","volume":"46","author":"Olmos","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_6","first-page":"710928","article-title":"Metabolic Syndrome in Rheumatoid Arthritis","volume":"2013","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cai, W., Tang, X., and Pang, M. (2022). Prevalence of Metabolic Syndrome in Patients With Rheumatoid Arthritis: An Updated Systematic Review and Meta-Analysis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.855141"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14715\/cmb\/2022.68.6.28","article-title":"Rheumatoid Arthritis and Oxidative Stress","volume":"68","year":"2022","journal-title":"Cell Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ferreira, H.B., Melo, T., Paiva, A., and Domingues, M.D.R. (2021). Insights in the Role of Lipids, Oxidative Stress and Inflammation in Rheumatoid Arthritis Unveiled by New Trends in Lipidomic Investigations. Antioxidants, 10.","DOI":"10.3390\/antiox10010045"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.humimm.2013.06.009","article-title":"3-Nitrotyrosine: A Biomarker of Nitrogen Free Radical Species Modified Proteins in Systemic Autoimmunogenic Conditions","volume":"74","author":"Ahsan","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2008.04.010","article-title":"Protein Tyrosine Nitration\u2014Functional Alteration or Just a Biomarker?","volume":"45","author":"Souza","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.112.143214","article-title":"Increased Circulating Levels of 3-Nitrotyrosine Autoantibodies: Marker for or Maker of Cardiovascular Disease?","volume":"126","author":"Daiber","year":"2012","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/00207454.2020.1713776","article-title":"3-Nitrotyrosine: A Versatile Oxidative Stress Biomarker for Major Neurodegenerative Diseases","volume":"130","author":"Bandookwala","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1164\/rccm.201505-0992OC","article-title":"Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease","volume":"193","author":"Pennathur","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified Disease Activity Scores That Include Twenty-eight-joint Counts Development and Validation in a Prospective Longitudinal Study of Patients with Rheumatoid Arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A Simplified Disease Activity Index for Rheumatoid Arthritis for Use in Clinical Practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology"},{"key":"ref_18","first-page":"S100","article-title":"The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A Review of Their Usefulness and Validity in Rheumatoid Arthritis","volume":"23","author":"Aletaha","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/art.21235","article-title":"Remission and Active Disease in Rheumatoid Arthritis: Defining Criteria for Disease Activity States","volume":"52","author":"Aletaha","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2012-201491","article-title":"Definition of Treatment Response in Rheumatoid Arthritis Based on the Simplified and the Clinical Disease Activity Index","volume":"71","author":"Aletaha","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"ref_22","unstructured":"(2021). SCORE2 Risk Prediction Algorithms: New Models to Estimate 10-Year Risk of Cardiovascular Disease in Europe. Eur. Heart J., 42, 2439\u20132454."},{"key":"ref_23","unstructured":"(2025, April 30). Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/4337382\/."},{"key":"ref_24","unstructured":"(2025, April 30). Diagnostic Tests: The Erythrocyte Sedimentation Rate Range and Limitations of the Technique\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/13455726\/."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and Abuse of HOMA Modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","article-title":"Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004\u20132006\u20132011). An Update on Behalf of the Advisory Board of the 3rd, 4th and 5th Watching the Risk Symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-5793(94)00722-5","article-title":"Evidence for Nitric Oxide-Mediated Oxidative Damage in Chronic Inflammation. Nitrotyrosine in Serum and Synovial Fluid from Rheumatoid Patients","volume":"350","author":"Kaur","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_28","unstructured":"(2025, April 05). Localization of 3-nitrotyrosine to Rheumatoid and Normal Synovium\u2014Mapp\u20142001\u2014Arthritis & Rheumatism\u2014Wiley Online Library. Available online: https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/1529-0131%28200107%2944%3A7%3C1534%3A%3AAID-ART276%3E3.0.CO%3B2-%23."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cca.2006.01.020","article-title":"Prevalence of Anti-3-Nitrotyrosine Antibodies in the Joint Synovial Fluid of Patients with Rheumatoid Arthritis, Osteoarthritis and Systemic Lupus Erythematosus","volume":"370","author":"Khan","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.joca.2012.09.005","article-title":"Characterization of Nitrotyrosine as a Biomarker for Arthritis and Joint Injury","volume":"21","author":"Misko","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.freeradbiomed.2005.08.039","article-title":"Homocysteine from Endothelial Cells Promotes LDL Nitration and Scavenger Receptor Uptake","volume":"40","author":"Griffiths","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"708282","DOI":"10.1155\/2015\/708282","article-title":"3-Nitrotyrosine Modified Proteins in Atherosclerosis","volume":"2015","author":"Thomson","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.289.13.1675","article-title":"Association of Nitrotyrosine Levels with Cardiovascular Disease and Modulation by Statin Therapy","volume":"289","author":"Shishehbor","year":"2003","journal-title":"JAMA"},{"key":"ref_34","unstructured":"(2025, May 01). Increased Serum Levels of Nitrotyrosine, a Marker for Peroxynitrite Production, in Systemic Sclerosis\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/17543154\/."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1525-1381.1999.99110.x","article-title":"Prospective Measure of Serum 3-Nitrotyrosine Levels in Systemic Lupus Erythematosus: Correlation with Disease Activity","volume":"111","author":"Oates","year":"1999","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"ref_36","first-page":"318","article-title":"Correlation of Serum Measures of Nitric Oxide Production with Lupus Disease Activity","volume":"26","author":"Gilkeson","year":"1999","journal-title":"J. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/art.27442","article-title":"Markers of Oxidative and Nitrosative Stress in Systemic Lupus Erythematosus: Correlation with Disease Activity","volume":"62","author":"Wang","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/art.21130","article-title":"Increased Levels of Serum Protein Oxidation and Correlation with Disease Activity in Systemic Lupus Erythematosus","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_39","first-page":"189","article-title":"Antibodies against Nitric Oxide Damaged Poly L-Tyrosine and 3-Nitrotyrosine Levels in Systemic Lupus Erythematosus","volume":"39","author":"Khan","year":"2006","journal-title":"J. Biochem. Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-3083.2006.01794.x","article-title":"Measurement and Significance of 3-Nitrotyrosine in Systemic Lupus Erythematosus","volume":"64","author":"Khan","year":"2006","journal-title":"Scand. J. Immunol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/11\/1325\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:40:13Z","timestamp":1760031613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/11\/1325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["diagnostics15111325"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15111325","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]}}}